Navigation Links
UT researcher receives $2.4 million to research obesity, high-risk pregnancy
Date:2/12/2010

HOUSTON (Feb. 12, 2010) The link between obesity and high-risk pregnancies caused by preeclampsia and diabetes will be the focus of a $2.4 million National Institutes of Health research grant received by Sean Blackwell, M.D., associate professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences at The University of Texas Medical School at Houston.

Researchers hope the observational study will provide them with a better understanding of the cause, diagnosis and history of preeclampsia and diabetes in pregnant women and whether or not obese pregnant women and non-obese pregnant women are at the same risk of having complications during their pregnancy.

"We hope our findings from this study will be used to develop effective treatments and therapies and have the potential to save lives," said Blackwell, lead investigator of the grant and director of the Larry C. Gilstrap Center for Perinatal and Women's Health Research at the UT Medical School at Houston.

Preeclampsia is a leading cause of fetal complications including low birth weight, premature birth and stillbirth and is the second leading cause of maternal death in the United States. Signs of preeclampsia include increased blood pressure and protein in a mother's urine as a result of kidney problems, according to The Centers for Disease Control and Prevention (CDC). It can affect the placenta and the mother's kidney, liver and brain. The NIH estimates preeclampsia causes 15 percent of premature births and leads to the death of more than 50,000 women each year. The only effective treatment for preeclampsia is to immediately deliver the baby.

Diabetes affects two to ten percent of all pregnancies and can lead to miscarriage and stillbirth, according to the American Congress of Obstetricians and Gynecologists. Women with gestational diabetes and high blood glucose levels during pregnancy increase the risk of having a large baby and cesarean birth.

According to Blackwell, this study is novel because it focuses on pregnancies complicated by various degrees of obesity. Researchers will evaluate the role of blood vessels, fat proteins and other emerging molecules in the development of preeclampsia and gestational diabetes; explore the relationship between preeclampsia and gestational diabetes; and assess the association between a decrease in vaginal bacteria and preterm birth.

Blackwell and his team will follow non-obese and obese pregnant women with chronic hypertension and without diabetes, non-diabetic pregnant women with chronic hypertension with or without obesity, healthy obese pregnant women and healthy non-obese pregnant women. Participants will be followed from their first trimester through six weeks post-partum and researchers will assess changes in the metabolic parameters and blood vessel function of the mother, as well as changes in fetal growth.

Beginning April 1, participants will be recruited from physician's offices and prenatal clinics that deliver at Memorial Hermann Hospital-Texas Medical Center. The grant is in collaboration with The University of Texas Medical Branch at Galveston and George Saade, M.D., professor and director of maternal fetal medicine at UTMB. The four-year award comes from the NIH's Eunice Kennedy Shriver National Institute of Child Health and Development's Division of Epidemiology, Statistics and Prevention Research.


'/>"/>

Contact: Jade Waddy
jade.waddy@uth.tmc.edu
713-500-3030
University of Texas Health Science Center at Houston
Source:Eurekalert

Related medicine news :

1. MSU researcher linking breast cancer patients with alternative therapies
2. Researchers create drug to keep tumor growth switched off
3. Tiny fruit fly could offer big clues in fight against obesity, researcher says
4. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
5. Researchers discover new way to kill pediatric brain tumors
6. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
7. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
8. Researcher to track spread of disease, malware and power outages
9. UCSF Researchers Identify Regulator of Human Sperm Cells
10. Women should be allowed to eat, drink during labor: Queens University researcher
11. Researchers find broad spectrum antiviral that fights multitude of viruses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: